F. Kanakoudi-Tsakalidou

Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity.

S. Lampoudi, M. Trachana, A. Taparkou, 2011, Metabolism: clinical and experimental.

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis.

M. Theodoridou, M. Trachana, E. Farmaki, 2010, Vaccine.

Macrophage activation syndrome in a child with unclassified systemic vasculitis probably triggered by parvovirus B 19 infection

M. Trachana, M. Athanasiou-Metaxa, G. Pardalos, 2009 .

Evans syndrome: successful management with multi-agent treatment including intermediate-dose intravenous cyclophosphamide.

M. Athanassiou, N. Gombakis, F. Kanakoudi-Tsakalidou, 1999, Journal of pediatric hematology/oncology.

Humoral Immunity against Measles in Mother–Infant Pairs during the First Year of Life in Greece: A Cross-Sectional Study

E. Agakidou, F. Papachristou, A. Taparkou, 2021, Vaccines.

Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment

P. Bamidis, F. Papachristou, M. Trachana, 2018, Rheumatology International.

Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study

T. Dimitroulas, P. Sidiropoulos, M. Trachana, 2017, Rheumatology.